Taking a lifesciences company global: what to expect from an investor perspective. Paul Anderson – Orthocell. Investor Meets Innovator Takes Over Talking HealthTech!
During the holiday season, Pete and the team from Talking HealthTech are taking a well earned break, so while they’re away, the hosts of various shows from within the Talking HealthTech Podcast Network are sharing some of their favourite episodes from their own podcasts!
This episode is brought to you by Tracey Wilkinson, host of the Investor Meets Innovator Podcast by Life Sciences Western Australia.
About Investor Meets Innovator by LSWA:
In this limited podcast series, we’ve brought together a series of conversations with experts from medical science to finance to help demystify investing in biotech, medtech and digital health (also known as the life sciences).
This podcast has been brought to you by Life Sciences WA (Western Australia’s Life Sciences Industry Association) in collaboration with Talking HealthTech.
It has been possible with funding support from the West Australian government through the New Industries Fund and the REDI initiative, managed by MTPConnect on behalf of the Medical Research Future Fund and with the support of ANDHealth.
For more, follow Life Sciences WA on LinkedIn and Twitter or subscribe to the mailing list at lifescienceswa.com.au.
About This Episode:
In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Paul Anderson, the Managing Director of Orthocell. With over 25 years of experience in the medical space and a background in device development and regenerative medicine, Paul shares his insights on the life sciences industry and the journey of bringing innovative medical technologies to market.
Paul discusses the challenges and opportunities in the healthcare industry, particularly in Western Australia where the economy is heavily reliant on the mining industry. He emphasises the importance of intellectual property protection and the role it plays in generating value in products and advancements in manufacturing.
Through his own experiences with Orthocell, Paul highlights the crucial elements for success in the life sciences, including multidisciplinary teams, funding, faith, and patience. He dives into the lengthy and complex pathway to market for medical devices and pharmaceutical products, shedding light on the challenges investors in the industry need to understand and navigate.
Paul also shares the story of Orthocell’s pioneering technique to treat tetraplegic patients, resulting in improved mobility and life-changing outcomes for patients like Adrian. He explains the role of patient advocates, surgeons, and government support in developing successful and marketable technologies.
We’d love your feedback on this podcast series, please take a moment to complete this short survey: https://forms.office.com/r/W0R1cEtMjh
The Investor Meets Innovator Podcast is brought to you by Life Sciences WA. To stay updated on LSWA and connect, visit our website https://www.lifescienceswa.com.au
This show is a proud member of the Talking HealthTech Podcast Network – the premier audio destination for cutting-edge insights and thought leadership in healthcare delivery, innovation, digital health, healthcare ICT, and commercialisation. Learn more at www.talkinghealthtech.com/podcast/network.
Check out more episodes from The Good GP:
Apple Podcasts: https://podcasts.apple.com/us/podcast/life-sciences-wa-investment-series-investor-meets-innovator/id1660685214
Spotify: https://open.spotify.com/show/6UEdKH8spewetYPt0GcxLJ
